`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`Paper No. 7
`
`COMPLEX INNOVATIONS, LLC,
`Petitioner,
`
`v.
`
`ASTRAZENECA AB,
`Patent Owner.
`
`Case No. IPR2017-00631
`Patent No. 7,759,328
`
`PATENT OWNER ASTRAZENECA AB’S
`UPDATED MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
` DC: 6349559-1
`
`
`
`
`
`IPR2017-00631
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner AstraZeneca AB submits the
`
`following Updated Mandatory Notices. All other information remains unchanged.
`
`A. Lead and Back-Up Counsel Under 37 C.F.R. § 42.8(b)(3)
`
`Lead Counsel
`Christopher N. Sipes (Reg. No. 39,837)
`csipes@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5525
`Fax: (202) 778-5525
`
`
`Back-Up Counsel
`Andrea G. Reister (Reg. No. 36,253)
`areister@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5141
`Fax: (202) 778-5141
`Additional Back-Up Counsel
`Scott E. Kamholz (Reg. No. 48,543)
`skamholz@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5339
`Fax: (202) 778-5339
`
`B. Service Information Under 37 C.F.R. § 42.8(b)(4)
`
`
`
`Service information for lead and back-up counsel is provided in the
`
`designation of lead and back-up counsel, above. Service of any documents via
`
`hand-delivery may be made at the postal mailing address of the respective lead and
`
`back-up counsel designated above. Patent Owner AstraZeneca AB consents to
`
`electronic service by email at the above listed email addresses of lead and back-up
`
`counsel.
`
`
`
`
`
`
`
`Power of Attorney
`
`IPR2017-00631
`
`A Power of Attorney to transact all business in the United States Patent &
`
`Trademark Office (“USPTO”) in connection with the above-referenced Inter Partes
`
`Review from Patent Owner AstraZeneca AB to the above-designated counsel at
`
`Covington & Burling LLP is being filed concurrently with these Mandatory Notices.
`
`The Power of Attorney is accompanied by a Statement Under 37 C.F.R. § 3.73(b),
`
`Respectfully submitted,
`
`
`
`
`
`By: /s/Andrea G. Reister
`Christopher N. Sipes
` Registration No. 39,837
`Andrea G. Reister
` Registration No. 36,253
`COVINGTON & BURLING LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`executed by the Patent Owner.
`
`
`Date: April 12, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that on this 12th day of April 2017, the
`
`foregoing Patent Owner AstraZeneca AB’s Updated Mandatory Notices was served
`
`by electronic mail and FedEx, a means at least as fast and reliable as Priority Mail
`
`Express®, on the following counsel of record for petitioner.
`
`
`
`Sharad K. Bijanki (sb@hkw-law.com)
`Vivek Ganti (vg@hkw-law.com)
`Hill, Kertscher & Wharton, LLP
`3350 Riverwood Parkway SE, Suite 800
`Atlanta, GA 30339
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /s/Andrea G. Reister
`Andrea G. Reister, Esq.
`Registration No.: 36,253
`
`
`
`
`
`
`
`Date: April 12, 2017
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`